Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.
Financial Summary: BRIEF: For the three months ended 31 January 2024, Agilent Technologies Inc revenues decreased 6% to $1.66B. Net income decreased 1% to $348M. Revenues reflect Life Sciences and Applied Markets segment decrease of 18% to $846M, United States segment decrease of 8% to $630M, Asia Pacific segment decrease of 7% to $570M. Net income also reflects Life Sciences and Applied Markets segment income decrease of 25% to $236M.